Investigational monoclonal antibody to treat Ebola is safe in adults
The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal ...
Jan 25, 2019
0
0